Standard Biotools Inc (LAB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2015 | 06-2015 | 03-2015 | 12-2014 | 09-2014 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 97,070 | 23,745 | 36,982 | 33,713 | 30,939 |
| Marketable Securities | N/A | 76,181 | 79,424 | 81,588 | 64,324 |
| Receivables | 26,248 | 21,786 | 19,577 | 22,384 | 16,919 |
| Inventories | 19,141 | 18,817 | 17,394 | 15,991 | 16,960 |
| TOTAL | $145,450 | $143,380 | $155,233 | $155,897 | $132,820 |
| Non-Current Assets | |||||
| PPE Net | 14,358 | 14,102 | 14,053 | 13,889 | 12,668 |
| Investments And Advances | 17,033 | 27,119 | 18,508 | 27,499 | 51,962 |
| Intangibles | 197,958 | 200,708 | 203,508 | 206,308 | 209,245 |
| Other Non-Current Assets | 3,688 | 3,820 | 3,729 | 3,966 | 3,698 |
| TOTAL | $233,037 | $245,749 | $239,798 | $251,662 | $277,573 |
| Total Assets | $378,487 | $389,129 | $395,031 | $407,559 | $410,393 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 6,303 | 5,964 | 5,502 | 5,919 | 7,276 |
| Accrued Expenses | 3,586 | 5,047 | 4,840 | 6,874 | 6,034 |
| TOTAL | $27,481 | $28,930 | $24,904 | $29,385 | $27,306 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 8,179 | 7,547 | 7,346 | 6,928 | 6,630 |
| Other Non-Current Liabilities | 197,763 | 197,668 | 197,234 | 197,246 | 197,016 |
| TOTAL | $226,880 | $226,982 | $227,674 | $227,755 | $228,532 |
| Total Liabilities | $254,361 | $255,912 | $252,578 | $257,140 | $255,838 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 28,792 | 28,713 | 28,785 | 28,368 | 28,254 |
| Common Shares | 29 | 29 | 29 | 28 | 28 |
| Retained earnings | -350,613 | -341,344 | -326,108 | -310,177 | -299,233 |
| Other shareholders' equity | -794 | -697 | -600 | -794 | -802 |
| TOTAL | $124,126 | $133,217 | $142,453 | $150,419 | $154,555 |
| Total Liabilities And Equity | $378,487 | $389,129 | $395,031 | $407,559 | $410,393 |